Form 4: Axon Director Sells Shares Under 10b5-1 Trading Plan

Axon Enterprise director Michael Garnreiter sold 1,000 shares of common stock on December 16, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Michael Garnreiter, a director at Axon Enterprise, Inc., sold a total of 1,000 shares of common stock on December 16, 2024.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 17, 2024.
• The transactions occurred in multiple trades at varying prices, ranging from $616.65 to $652.05 per share.
• The weighted average sale prices for some of the transactions were $633.7967, $643.795, $646.9757 and $649.3433.
• Following these transactions, Garnreiter's direct holdings decreased to 24,259 shares.

Sentiment

Score: 5

Explanation: The document reflects a routine insider sale under a pre-arranged plan, which is neither particularly positive nor negative.

Risks

• Sales by insiders, even under pre-arranged plans, can sometimes be perceived negatively by the market.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and these transactions are closely monitored by regulators and investors.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are a common practice for corporate insiders to sell shares while avoiding accusations of trading on non-public information.
• The reported transactions are typical for a director selling shares under a pre-arranged plan.
• The volume of shares sold is relatively small compared to the overall market capitalization of Axon.

Stakeholder Impact

• The impact on shareholders is likely to be minimal, as the sales were part of a pre-arranged plan and the volume was not significant.

Key Dates

Keywords

Axon, insider trading, Form 4, stock sale, 10b5-1 plan, Michael Garnreiter, director